Cite
HARVARD Citation
Sparano, J. et al. (2021). Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer. Journal of clinical oncology. 39 (6), pp. 557-564. [Online].